Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Nuvation Bio Inc., a pharmaceutical company focused on cancer treatment with a market capitalization of $769 million, announced the departure of Dr. Jerry Wang, CEO of subsidiary AnHeart Therapeutics, ...

February 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Nuvation Bio Inc. (NYSE: NUVB) breached their fiduciary duties to ...

Nuvation Bio (NUVB) announced it has initiated an Expanded Access Program or EAP for taletrectinib in the U.S. for the treatment of patients ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Every investor in Nuvation Bio Inc. (NYSE:NUVB) should be aware of the most powerful shareholder groups. With 46% stake, institutions possess the maximum shares in the company. In other words ...

Every investor in Nuvation Bio Inc. (NYSE:NUVB) should be aware of the most powerful shareholder groups. With 46% stake, institutions possess the maximum shares in the company. In other words, the ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology,... Director of Nuvation ...

Nuvation Bio Inc. (NUVB) stock price is 2.50 and Nuvation Bio Inc. (NUVB) 10-day simple moving average is 2.62. Nuvation Bio Inc. (NUVB) stock price is 2.50 and Nuvation Bio Inc. (NUVB ...